nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A4—Temozolomide—brain cancer	0.103	0.387	CbGbCtD
Zaleplon—CYP3A4—Lomustine—brain cancer	0.088	0.329	CbGbCtD
Zaleplon—CYP3A5—Etoposide—brain cancer	0.0545	0.204	CbGbCtD
Zaleplon—CYP3A4—Etoposide—brain cancer	0.0213	0.0796	CbGbCtD
Zaleplon—GABRA2—ganglion—brain cancer	0.00786	0.047	CbGeAlD
Zaleplon—AOX1—Effects of Nitric Oxide—MB—brain cancer	0.00695	0.357	CbGpPWpGaD
Zaleplon—GABRB2—hindbrain—brain cancer	0.00653	0.039	CbGeAlD
Zaleplon—GABRA2—hindbrain—brain cancer	0.00596	0.0356	CbGeAlD
Zaleplon—TSPO—blood vessel—brain cancer	0.00579	0.0346	CbGeAlD
Zaleplon—GABRA1—hindbrain—brain cancer	0.00576	0.0344	CbGeAlD
Zaleplon—GABRB2—brainstem—brain cancer	0.00374	0.0224	CbGeAlD
Zaleplon—GABRA2—brainstem—brain cancer	0.00342	0.0204	CbGeAlD
Zaleplon—GABRG2—telencephalon—brain cancer	0.00332	0.0198	CbGeAlD
Zaleplon—GABRB2—telencephalon—brain cancer	0.00332	0.0198	CbGeAlD
Zaleplon—GABRA1—brainstem—brain cancer	0.0033	0.0197	CbGeAlD
Zaleplon—TSPO—brainstem—brain cancer	0.00316	0.0189	CbGeAlD
Zaleplon—CYP3A7—endocrine gland—brain cancer	0.00312	0.0186	CbGeAlD
Zaleplon—GABRA2—telencephalon—brain cancer	0.00303	0.0181	CbGeAlD
Zaleplon—GABRA1—telencephalon—brain cancer	0.00293	0.0175	CbGeAlD
Zaleplon—TSPO—telencephalon—brain cancer	0.00281	0.0168	CbGeAlD
Zaleplon—AOX1—gonad—brain cancer	0.00274	0.0164	CbGeAlD
Zaleplon—GABRG2—pituitary gland—brain cancer	0.0027	0.0162	CbGeAlD
Zaleplon—AOX1—pituitary gland—brain cancer	0.00268	0.016	CbGeAlD
Zaleplon—GABRB2—medulla oblongata—brain cancer	0.00261	0.0156	CbGeAlD
Zaleplon—GABRG2—medulla oblongata—brain cancer	0.00261	0.0156	CbGeAlD
Zaleplon—GABRB3—telencephalon—brain cancer	0.00255	0.0152	CbGeAlD
Zaleplon—GABRG2—midbrain—brain cancer	0.00238	0.0142	CbGeAlD
Zaleplon—GABRB2—midbrain—brain cancer	0.00238	0.0142	CbGeAlD
Zaleplon—TSPO—gonad—brain cancer	0.00234	0.014	CbGeAlD
Zaleplon—GABRB2—spinal cord—brain cancer	0.00233	0.0139	CbGeAlD
Zaleplon—GABRG2—spinal cord—brain cancer	0.00233	0.0139	CbGeAlD
Zaleplon—GABRA1—medulla oblongata—brain cancer	0.0023	0.0138	CbGeAlD
Zaleplon—TSPO—pituitary gland—brain cancer	0.00229	0.0137	CbGeAlD
Zaleplon—TSPO—medulla oblongata—brain cancer	0.00221	0.0132	CbGeAlD
Zaleplon—GABRB3—gonad—brain cancer	0.00213	0.0127	CbGeAlD
Zaleplon—GABRA1—midbrain—brain cancer	0.0021	0.0126	CbGeAlD
Zaleplon—GABRB3—pituitary gland—brain cancer	0.00208	0.0124	CbGeAlD
Zaleplon—AOX1—endocrine gland—brain cancer	0.00207	0.0124	CbGeAlD
Zaleplon—GABRB2—head—brain cancer	0.00207	0.0124	CbGeAlD
Zaleplon—GABRG2—head—brain cancer	0.00207	0.0124	CbGeAlD
Zaleplon—GABRA1—spinal cord—brain cancer	0.00205	0.0123	CbGeAlD
Zaleplon—TSPO—midbrain—brain cancer	0.00202	0.012	CbGeAlD
Zaleplon—GABRB3—medulla oblongata—brain cancer	0.002	0.012	CbGeAlD
Zaleplon—TSPO—spinal cord—brain cancer	0.00197	0.0118	CbGeAlD
Zaleplon—GABRA2—head—brain cancer	0.00189	0.0113	CbGeAlD
Zaleplon—GABRG2—central nervous system—brain cancer	0.00189	0.0113	CbGeAlD
Zaleplon—GABRB2—central nervous system—brain cancer	0.00189	0.0113	CbGeAlD
Zaleplon—GABRG2—cerebellum—brain cancer	0.00184	0.011	CbGeAlD
Zaleplon—GABRB2—cerebellum—brain cancer	0.00184	0.011	CbGeAlD
Zaleplon—GABRB3—midbrain—brain cancer	0.00183	0.0109	CbGeAlD
Zaleplon—AOX1—cerebellum—brain cancer	0.00183	0.0109	CbGeAlD
Zaleplon—GABRA1—head—brain cancer	0.00182	0.0109	CbGeAlD
Zaleplon—GABRB3—spinal cord—brain cancer	0.00179	0.0107	CbGeAlD
Zaleplon—TSPO—endocrine gland—brain cancer	0.00177	0.0106	CbGeAlD
Zaleplon—TSPO—head—brain cancer	0.00175	0.0104	CbGeAlD
Zaleplon—GABRA2—central nervous system—brain cancer	0.00172	0.0103	CbGeAlD
Zaleplon—GABRA2—cerebellum—brain cancer	0.00168	0.0101	CbGeAlD
Zaleplon—GABRA1—central nervous system—brain cancer	0.00167	0.00996	CbGeAlD
Zaleplon—GABRA1—cerebellum—brain cancer	0.00163	0.00973	CbGeAlD
Zaleplon—GABRB3—endocrine gland—brain cancer	0.00161	0.00961	CbGeAlD
Zaleplon—TSPO—central nervous system—brain cancer	0.0016	0.00954	CbGeAlD
Zaleplon—GABRB3—head—brain cancer	0.00159	0.00949	CbGeAlD
Zaleplon—TSPO—cerebellum—brain cancer	0.00156	0.00932	CbGeAlD
Zaleplon—GABRG2—brain—brain cancer	0.0015	0.00895	CbGeAlD
Zaleplon—GABRB2—brain—brain cancer	0.0015	0.00895	CbGeAlD
Zaleplon—Diplopia—Temozolomide—brain cancer	0.00149	0.00273	CcSEcCtD
Zaleplon—Face oedema—Carmustine—brain cancer	0.00149	0.00273	CcSEcCtD
Zaleplon—Mouth ulceration—Etoposide—brain cancer	0.00149	0.00272	CcSEcCtD
Zaleplon—AOX1—brain—brain cancer	0.00148	0.00886	CbGeAlD
Zaleplon—Affect lability—Temozolomide—brain cancer	0.00147	0.00269	CcSEcCtD
Zaleplon—Tension—Procarbazine—brain cancer	0.00146	0.00267	CcSEcCtD
Zaleplon—Ataxia—Carmustine—brain cancer	0.00145	0.00266	CcSEcCtD
Zaleplon—GABRB3—central nervous system—brain cancer	0.00145	0.00866	CbGeAlD
Zaleplon—Nervousness—Procarbazine—brain cancer	0.00144	0.00264	CcSEcCtD
Zaleplon—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00144	0.00264	CcSEcCtD
Zaleplon—Face oedema—Temozolomide—brain cancer	0.00144	0.00264	CcSEcCtD
Zaleplon—Stomatitis—Hydroxyurea—brain cancer	0.00143	0.00263	CcSEcCtD
Zaleplon—Liver function test abnormal—Carmustine—brain cancer	0.00142	0.00261	CcSEcCtD
Zaleplon—GABRB3—cerebellum—brain cancer	0.00142	0.00846	CbGeAlD
Zaleplon—Mood swings—Temozolomide—brain cancer	0.00141	0.00259	CcSEcCtD
Zaleplon—Ataxia—Temozolomide—brain cancer	0.0014	0.00257	CcSEcCtD
Zaleplon—Tremor—Procarbazine—brain cancer	0.00139	0.00255	CcSEcCtD
Zaleplon—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00139	0.00255	CcSEcCtD
Zaleplon—Anaemia—Procarbazine—brain cancer	0.00137	0.00251	CcSEcCtD
Zaleplon—GABRA2—brain—brain cancer	0.00137	0.00818	CbGeAlD
Zaleplon—Dry skin—Temozolomide—brain cancer	0.00137	0.0025	CcSEcCtD
Zaleplon—Muscular weakness—Carmustine—brain cancer	0.00136	0.00249	CcSEcCtD
Zaleplon—Swelling—Etoposide—brain cancer	0.00135	0.00248	CcSEcCtD
Zaleplon—Breast disorder—Temozolomide—brain cancer	0.00135	0.00247	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00134	0.00246	CcSEcCtD
Zaleplon—Dysphagia—Carmustine—brain cancer	0.00133	0.00244	CcSEcCtD
Zaleplon—Syncope—Procarbazine—brain cancer	0.00133	0.00244	CcSEcCtD
Zaleplon—GABRA1—brain—brain cancer	0.00132	0.0079	CbGeAlD
Zaleplon—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00132	0.00241	CcSEcCtD
Zaleplon—Muscular weakness—Temozolomide—brain cancer	0.00132	0.00241	CcSEcCtD
Zaleplon—Hallucination—Hydroxyurea—brain cancer	0.00131	0.00241	CcSEcCtD
Zaleplon—Loss of consciousness—Procarbazine—brain cancer	0.00131	0.00239	CcSEcCtD
Zaleplon—Dysphagia—Temozolomide—brain cancer	0.00129	0.00236	CcSEcCtD
Zaleplon—Hypertension—Procarbazine—brain cancer	0.00128	0.00235	CcSEcCtD
Zaleplon—TSPO—brain—brain cancer	0.00127	0.00757	CbGeAlD
Zaleplon—Arthralgia—Procarbazine—brain cancer	0.00126	0.00232	CcSEcCtD
Zaleplon—Myalgia—Procarbazine—brain cancer	0.00126	0.00232	CcSEcCtD
Zaleplon—Anxiety—Procarbazine—brain cancer	0.00126	0.00231	CcSEcCtD
Zaleplon—Bronchitis—Temozolomide—brain cancer	0.00124	0.00227	CcSEcCtD
Zaleplon—Dry mouth—Procarbazine—brain cancer	0.00124	0.00227	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Etoposide—brain cancer	0.00123	0.00226	CcSEcCtD
Zaleplon—Confusional state—Procarbazine—brain cancer	0.00122	0.00224	CcSEcCtD
Zaleplon—Oedema—Procarbazine—brain cancer	0.00121	0.00222	CcSEcCtD
Zaleplon—Dysuria—Temozolomide—brain cancer	0.00121	0.00221	CcSEcCtD
Zaleplon—Hyperglycaemia—Carmustine—brain cancer	0.0012	0.0022	CcSEcCtD
Zaleplon—Pneumonia—Carmustine—brain cancer	0.0012	0.00219	CcSEcCtD
Zaleplon—Shock—Procarbazine—brain cancer	0.00119	0.00218	CcSEcCtD
Zaleplon—Pollakiuria—Temozolomide—brain cancer	0.00119	0.00218	CcSEcCtD
Zaleplon—Erectile dysfunction—Temozolomide—brain cancer	0.00119	0.00217	CcSEcCtD
Zaleplon—Depression—Carmustine—brain cancer	0.00119	0.00217	CcSEcCtD
Zaleplon—Chills—Hydroxyurea—brain cancer	0.00119	0.00217	CcSEcCtD
Zaleplon—Tachycardia—Procarbazine—brain cancer	0.00118	0.00217	CcSEcCtD
Zaleplon—Photosensitivity reaction—Temozolomide—brain cancer	0.00118	0.00215	CcSEcCtD
Zaleplon—Weight increased—Temozolomide—brain cancer	0.00117	0.00215	CcSEcCtD
Zaleplon—Hyperhidrosis—Procarbazine—brain cancer	0.00117	0.00215	CcSEcCtD
Zaleplon—Alopecia—Hydroxyurea—brain cancer	0.00117	0.00214	CcSEcCtD
Zaleplon—Weight decreased—Temozolomide—brain cancer	0.00117	0.00214	CcSEcCtD
Zaleplon—Neuropathy peripheral—Carmustine—brain cancer	0.00117	0.00214	CcSEcCtD
Zaleplon—Hyperglycaemia—Temozolomide—brain cancer	0.00116	0.00213	CcSEcCtD
Zaleplon—Stomatitis—Carmustine—brain cancer	0.00116	0.00212	CcSEcCtD
Zaleplon—Pneumonia—Temozolomide—brain cancer	0.00116	0.00212	CcSEcCtD
Zaleplon—Anorexia—Procarbazine—brain cancer	0.00116	0.00212	CcSEcCtD
Zaleplon—GABRB3—brain—brain cancer	0.00115	0.00687	CbGeAlD
Zaleplon—Depression—Temozolomide—brain cancer	0.00115	0.0021	CcSEcCtD
Zaleplon—Nausea—Lomustine—brain cancer	0.00113	0.00208	CcSEcCtD
Zaleplon—Hypotension—Procarbazine—brain cancer	0.00113	0.00207	CcSEcCtD
Zaleplon—Neuropathy peripheral—Temozolomide—brain cancer	0.00113	0.00206	CcSEcCtD
Zaleplon—Stomatitis—Temozolomide—brain cancer	0.00112	0.00205	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Procarbazine—brain cancer	0.0011	0.00202	CcSEcCtD
Zaleplon—CYP3A5—endocrine gland—brain cancer	0.0011	0.00655	CbGeAlD
Zaleplon—Insomnia—Procarbazine—brain cancer	0.0011	0.00201	CcSEcCtD
Zaleplon—Paraesthesia—Procarbazine—brain cancer	0.00109	0.00199	CcSEcCtD
Zaleplon—Hepatobiliary disease—Temozolomide—brain cancer	0.00109	0.00199	CcSEcCtD
Zaleplon—Somnolence—Procarbazine—brain cancer	0.00108	0.00197	CcSEcCtD
Zaleplon—Ill-defined disorder—Hydroxyurea—brain cancer	0.00107	0.00195	CcSEcCtD
Zaleplon—Anaemia—Hydroxyurea—brain cancer	0.00106	0.00195	CcSEcCtD
Zaleplon—Hallucination—Carmustine—brain cancer	0.00106	0.00195	CcSEcCtD
Zaleplon—Hypoaesthesia—Carmustine—brain cancer	0.00106	0.00195	CcSEcCtD
Zaleplon—Decreased appetite—Procarbazine—brain cancer	0.00105	0.00193	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Etoposide—brain cancer	0.00105	0.00193	CcSEcCtD
Zaleplon—Oedema peripheral—Carmustine—brain cancer	0.00105	0.00193	CcSEcCtD
Zaleplon—Malaise—Hydroxyurea—brain cancer	0.00104	0.0019	CcSEcCtD
Zaleplon—Constipation—Procarbazine—brain cancer	0.00104	0.0019	CcSEcCtD
Zaleplon—Pain—Procarbazine—brain cancer	0.00104	0.0019	CcSEcCtD
Zaleplon—Dysphagia—Etoposide—brain cancer	0.00103	0.00189	CcSEcCtD
Zaleplon—Visual impairment—Carmustine—brain cancer	0.00103	0.00188	CcSEcCtD
Zaleplon—Hallucination—Temozolomide—brain cancer	0.00103	0.00188	CcSEcCtD
Zaleplon—Hypoaesthesia—Temozolomide—brain cancer	0.00103	0.00188	CcSEcCtD
Zaleplon—Oedema peripheral—Temozolomide—brain cancer	0.00102	0.00186	CcSEcCtD
Zaleplon—Feeling abnormal—Procarbazine—brain cancer	0.000999	0.00183	CcSEcCtD
Zaleplon—Eye disorder—Carmustine—brain cancer	0.000998	0.00183	CcSEcCtD
Zaleplon—Visual impairment—Temozolomide—brain cancer	0.000994	0.00182	CcSEcCtD
Zaleplon—Gastrointestinal pain—Procarbazine—brain cancer	0.000991	0.00182	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000972	0.00178	CcSEcCtD
Zaleplon—Discomfort—Hydroxyurea—brain cancer	0.000967	0.00177	CcSEcCtD
Zaleplon—Eye disorder—Temozolomide—brain cancer	0.000964	0.00177	CcSEcCtD
Zaleplon—Urticaria—Procarbazine—brain cancer	0.000963	0.00176	CcSEcCtD
Zaleplon—Tinnitus—Temozolomide—brain cancer	0.000962	0.00176	CcSEcCtD
Zaleplon—Abdominal pain—Procarbazine—brain cancer	0.000958	0.00176	CcSEcCtD
Zaleplon—Body temperature increased—Procarbazine—brain cancer	0.000958	0.00176	CcSEcCtD
Zaleplon—Alopecia—Carmustine—brain cancer	0.000943	0.00173	CcSEcCtD
Zaleplon—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.000941	0.0484	CbGpPWpGaD
Zaleplon—Oedema—Hydroxyurea—brain cancer	0.000938	0.00172	CcSEcCtD
Zaleplon—Mental disorder—Carmustine—brain cancer	0.000935	0.00171	CcSEcCtD
Zaleplon—Immune system disorder—Temozolomide—brain cancer	0.000932	0.00171	CcSEcCtD
Zaleplon—Malnutrition—Carmustine—brain cancer	0.000929	0.0017	CcSEcCtD
Zaleplon—Chills—Temozolomide—brain cancer	0.000926	0.0017	CcSEcCtD
Zaleplon—Pneumonia—Etoposide—brain cancer	0.000925	0.00169	CcSEcCtD
Zaleplon—Nervous system disorder—Hydroxyurea—brain cancer	0.00092	0.00169	CcSEcCtD
Zaleplon—Alopecia—Temozolomide—brain cancer	0.000912	0.00167	CcSEcCtD
Zaleplon—Skin disorder—Hydroxyurea—brain cancer	0.000911	0.00167	CcSEcCtD
Zaleplon—Mental disorder—Temozolomide—brain cancer	0.000904	0.00166	CcSEcCtD
Zaleplon—Neuropathy peripheral—Etoposide—brain cancer	0.000902	0.00165	CcSEcCtD
Zaleplon—Back pain—Carmustine—brain cancer	0.000899	0.00165	CcSEcCtD
Zaleplon—Malnutrition—Temozolomide—brain cancer	0.000898	0.00164	CcSEcCtD
Zaleplon—Stomatitis—Etoposide—brain cancer	0.000896	0.00164	CcSEcCtD
Zaleplon—Anorexia—Hydroxyurea—brain cancer	0.000894	0.00164	CcSEcCtD
Zaleplon—Dysgeusia—Temozolomide—brain cancer	0.00088	0.00161	CcSEcCtD
Zaleplon—Tremor—Carmustine—brain cancer	0.000871	0.00159	CcSEcCtD
Zaleplon—Asthenia—Procarbazine—brain cancer	0.00087	0.00159	CcSEcCtD
Zaleplon—Hepatobiliary disease—Etoposide—brain cancer	0.00087	0.00159	CcSEcCtD
Zaleplon—Back pain—Temozolomide—brain cancer	0.000869	0.00159	CcSEcCtD
Zaleplon—Anaemia—Carmustine—brain cancer	0.000859	0.00157	CcSEcCtD
Zaleplon—Pruritus—Procarbazine—brain cancer	0.000858	0.00157	CcSEcCtD
Zaleplon—Agitation—Carmustine—brain cancer	0.000854	0.00156	CcSEcCtD
Zaleplon—Tremor—Temozolomide—brain cancer	0.000841	0.00154	CcSEcCtD
Zaleplon—Dyspnoea—Hydroxyurea—brain cancer	0.000837	0.00153	CcSEcCtD
Zaleplon—Somnolence—Hydroxyurea—brain cancer	0.000834	0.00153	CcSEcCtD
Zaleplon—Ill-defined disorder—Temozolomide—brain cancer	0.000833	0.00153	CcSEcCtD
Zaleplon—Anaemia—Temozolomide—brain cancer	0.00083	0.00152	CcSEcCtD
Zaleplon—Dyspepsia—Hydroxyurea—brain cancer	0.000826	0.00151	CcSEcCtD
Zaleplon—Agitation—Temozolomide—brain cancer	0.000825	0.00151	CcSEcCtD
Zaleplon—CYP3A4—endocrine gland—brain cancer	0.000823	0.00492	CbGeAlD
Zaleplon—Hypoaesthesia—Etoposide—brain cancer	0.000821	0.0015	CcSEcCtD
Zaleplon—Angioedema—Temozolomide—brain cancer	0.000821	0.0015	CcSEcCtD
Zaleplon—Decreased appetite—Hydroxyurea—brain cancer	0.000816	0.00149	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00081	0.00148	CcSEcCtD
Zaleplon—Malaise—Temozolomide—brain cancer	0.00081	0.00148	CcSEcCtD
Zaleplon—Vertigo—Temozolomide—brain cancer	0.000807	0.00148	CcSEcCtD
Zaleplon—Hypertension—Carmustine—brain cancer	0.000802	0.00147	CcSEcCtD
Zaleplon—Pain—Hydroxyurea—brain cancer	0.000802	0.00147	CcSEcCtD
Zaleplon—Constipation—Hydroxyurea—brain cancer	0.000802	0.00147	CcSEcCtD
Zaleplon—Dizziness—Procarbazine—brain cancer	0.000802	0.00147	CcSEcCtD
Zaleplon—Palpitations—Temozolomide—brain cancer	0.000794	0.00145	CcSEcCtD
Zaleplon—Chest pain—Carmustine—brain cancer	0.000791	0.00145	CcSEcCtD
Zaleplon—Myalgia—Carmustine—brain cancer	0.000791	0.00145	CcSEcCtD
Zaleplon—Anxiety—Carmustine—brain cancer	0.000789	0.00144	CcSEcCtD
Zaleplon—Hypertension—Temozolomide—brain cancer	0.000775	0.00142	CcSEcCtD
Zaleplon—Feeling abnormal—Hydroxyurea—brain cancer	0.000773	0.00142	CcSEcCtD
Zaleplon—Eye disorder—Etoposide—brain cancer	0.000772	0.00141	CcSEcCtD
Zaleplon—Confusional state—Carmustine—brain cancer	0.000765	0.0014	CcSEcCtD
Zaleplon—Arthralgia—Temozolomide—brain cancer	0.000765	0.0014	CcSEcCtD
Zaleplon—Myalgia—Temozolomide—brain cancer	0.000765	0.0014	CcSEcCtD
Zaleplon—Rash—Procarbazine—brain cancer	0.000764	0.0014	CcSEcCtD
Zaleplon—Dermatitis—Procarbazine—brain cancer	0.000764	0.0014	CcSEcCtD
Zaleplon—Anxiety—Temozolomide—brain cancer	0.000762	0.0014	CcSEcCtD
Zaleplon—Headache—Procarbazine—brain cancer	0.00076	0.00139	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000759	0.00139	CcSEcCtD
Zaleplon—Oedema—Carmustine—brain cancer	0.000759	0.00139	CcSEcCtD
Zaleplon—Discomfort—Temozolomide—brain cancer	0.000755	0.00138	CcSEcCtD
Zaleplon—Dry mouth—Temozolomide—brain cancer	0.000748	0.00137	CcSEcCtD
Zaleplon—Immune system disorder—Etoposide—brain cancer	0.000746	0.00137	CcSEcCtD
Zaleplon—Body temperature increased—Hydroxyurea—brain cancer	0.000742	0.00136	CcSEcCtD
Zaleplon—CYP3A4—central nervous system—brain cancer	0.000742	0.00443	CbGeAlD
Zaleplon—Chills—Etoposide—brain cancer	0.000741	0.00136	CcSEcCtD
Zaleplon—Tachycardia—Carmustine—brain cancer	0.00074	0.00136	CcSEcCtD
Zaleplon—Confusional state—Temozolomide—brain cancer	0.000739	0.00135	CcSEcCtD
Zaleplon—Anaphylactic shock—Temozolomide—brain cancer	0.000733	0.00134	CcSEcCtD
Zaleplon—Oedema—Temozolomide—brain cancer	0.000733	0.00134	CcSEcCtD
Zaleplon—Alopecia—Etoposide—brain cancer	0.00073	0.00134	CcSEcCtD
Zaleplon—Anorexia—Carmustine—brain cancer	0.000723	0.00132	CcSEcCtD
Zaleplon—Nausea—Procarbazine—brain cancer	0.00072	0.00132	CcSEcCtD
Zaleplon—Nervous system disorder—Temozolomide—brain cancer	0.000719	0.00132	CcSEcCtD
Zaleplon—Skin disorder—Temozolomide—brain cancer	0.000712	0.0013	CcSEcCtD
Zaleplon—Hypotension—Carmustine—brain cancer	0.000709	0.0013	CcSEcCtD
Zaleplon—Hyperhidrosis—Temozolomide—brain cancer	0.000709	0.0013	CcSEcCtD
Zaleplon—Dysgeusia—Etoposide—brain cancer	0.000704	0.00129	CcSEcCtD
Zaleplon—Anorexia—Temozolomide—brain cancer	0.000699	0.00128	CcSEcCtD
Zaleplon—Back pain—Etoposide—brain cancer	0.000695	0.00127	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Carmustine—brain cancer	0.000691	0.00127	CcSEcCtD
Zaleplon—Insomnia—Carmustine—brain cancer	0.000686	0.00126	CcSEcCtD
Zaleplon—Paraesthesia—Carmustine—brain cancer	0.000681	0.00125	CcSEcCtD
Zaleplon—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000681	0.035	CbGpPWpGaD
Zaleplon—Dyspnoea—Carmustine—brain cancer	0.000676	0.00124	CcSEcCtD
Zaleplon—Somnolence—Carmustine—brain cancer	0.000674	0.00123	CcSEcCtD
Zaleplon—Asthenia—Hydroxyurea—brain cancer	0.000673	0.00123	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000668	0.00122	CcSEcCtD
Zaleplon—Ill-defined disorder—Etoposide—brain cancer	0.000667	0.00122	CcSEcCtD
Zaleplon—Anaemia—Etoposide—brain cancer	0.000664	0.00122	CcSEcCtD
Zaleplon—Insomnia—Temozolomide—brain cancer	0.000663	0.00121	CcSEcCtD
Zaleplon—Decreased appetite—Carmustine—brain cancer	0.000659	0.00121	CcSEcCtD
Zaleplon—Paraesthesia—Temozolomide—brain cancer	0.000658	0.00121	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Carmustine—brain cancer	0.000655	0.0012	CcSEcCtD
Zaleplon—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000654	0.0337	CbGpPWpGaD
Zaleplon—Dyspnoea—Temozolomide—brain cancer	0.000654	0.0012	CcSEcCtD
Zaleplon—Somnolence—Temozolomide—brain cancer	0.000652	0.00119	CcSEcCtD
Zaleplon—Constipation—Carmustine—brain cancer	0.000649	0.00119	CcSEcCtD
Zaleplon—Pain—Carmustine—brain cancer	0.000649	0.00119	CcSEcCtD
Zaleplon—Malaise—Etoposide—brain cancer	0.000648	0.00119	CcSEcCtD
Zaleplon—Vertigo—Etoposide—brain cancer	0.000646	0.00118	CcSEcCtD
Zaleplon—Dyspepsia—Temozolomide—brain cancer	0.000645	0.00118	CcSEcCtD
Zaleplon—Decreased appetite—Temozolomide—brain cancer	0.000637	0.00117	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Temozolomide—brain cancer	0.000633	0.00116	CcSEcCtD
Zaleplon—Loss of consciousness—Etoposide—brain cancer	0.000632	0.00116	CcSEcCtD
Zaleplon—Constipation—Temozolomide—brain cancer	0.000627	0.00115	CcSEcCtD
Zaleplon—Pain—Temozolomide—brain cancer	0.000627	0.00115	CcSEcCtD
Zaleplon—Feeling abnormal—Carmustine—brain cancer	0.000625	0.00114	CcSEcCtD
Zaleplon—Hypertension—Etoposide—brain cancer	0.000621	0.00114	CcSEcCtD
Zaleplon—Dizziness—Hydroxyurea—brain cancer	0.00062	0.00114	CcSEcCtD
Zaleplon—Gastrointestinal pain—Carmustine—brain cancer	0.00062	0.00114	CcSEcCtD
Zaleplon—Chest pain—Etoposide—brain cancer	0.000612	0.00112	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000608	0.00111	CcSEcCtD
Zaleplon—Discomfort—Etoposide—brain cancer	0.000605	0.00111	CcSEcCtD
Zaleplon—Feeling abnormal—Temozolomide—brain cancer	0.000604	0.00111	CcSEcCtD
Zaleplon—Abdominal pain—Carmustine—brain cancer	0.0006	0.0011	CcSEcCtD
Zaleplon—Body temperature increased—Carmustine—brain cancer	0.0006	0.0011	CcSEcCtD
Zaleplon—Gastrointestinal pain—Temozolomide—brain cancer	0.000599	0.0011	CcSEcCtD
Zaleplon—Rash—Hydroxyurea—brain cancer	0.000592	0.00108	CcSEcCtD
Zaleplon—Confusional state—Etoposide—brain cancer	0.000591	0.00108	CcSEcCtD
Zaleplon—Dermatitis—Hydroxyurea—brain cancer	0.000591	0.00108	CcSEcCtD
Zaleplon—Headache—Hydroxyurea—brain cancer	0.000588	0.00108	CcSEcCtD
Zaleplon—Anaphylactic shock—Etoposide—brain cancer	0.000587	0.00107	CcSEcCtD
Zaleplon—Urticaria—Temozolomide—brain cancer	0.000582	0.00107	CcSEcCtD
Zaleplon—Abdominal pain—Temozolomide—brain cancer	0.000579	0.00106	CcSEcCtD
Zaleplon—Body temperature increased—Temozolomide—brain cancer	0.000579	0.00106	CcSEcCtD
Zaleplon—Tachycardia—Etoposide—brain cancer	0.000572	0.00105	CcSEcCtD
Zaleplon—Skin disorder—Etoposide—brain cancer	0.00057	0.00104	CcSEcCtD
Zaleplon—Hyperhidrosis—Etoposide—brain cancer	0.000567	0.00104	CcSEcCtD
Zaleplon—Anorexia—Etoposide—brain cancer	0.000559	0.00102	CcSEcCtD
Zaleplon—Nausea—Hydroxyurea—brain cancer	0.000557	0.00102	CcSEcCtD
Zaleplon—Hypotension—Etoposide—brain cancer	0.000548	0.001	CcSEcCtD
Zaleplon—Asthenia—Carmustine—brain cancer	0.000544	0.000997	CcSEcCtD
Zaleplon—Paraesthesia—Etoposide—brain cancer	0.000527	0.000965	CcSEcCtD
Zaleplon—Asthenia—Temozolomide—brain cancer	0.000526	0.000963	CcSEcCtD
Zaleplon—Dyspnoea—Etoposide—brain cancer	0.000523	0.000958	CcSEcCtD
Zaleplon—Somnolence—Etoposide—brain cancer	0.000521	0.000955	CcSEcCtD
Zaleplon—Pruritus—Temozolomide—brain cancer	0.000519	0.00095	CcSEcCtD
Zaleplon—Decreased appetite—Etoposide—brain cancer	0.00051	0.000934	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Etoposide—brain cancer	0.000506	0.000927	CcSEcCtD
Zaleplon—Dizziness—Carmustine—brain cancer	0.000502	0.000919	CcSEcCtD
Zaleplon—Pain—Etoposide—brain cancer	0.000502	0.000919	CcSEcCtD
Zaleplon—Constipation—Etoposide—brain cancer	0.000502	0.000919	CcSEcCtD
Zaleplon—Dizziness—Temozolomide—brain cancer	0.000485	0.000888	CcSEcCtD
Zaleplon—Feeling abnormal—Etoposide—brain cancer	0.000483	0.000885	CcSEcCtD
Zaleplon—Gastrointestinal pain—Etoposide—brain cancer	0.00048	0.000878	CcSEcCtD
Zaleplon—Rash—Carmustine—brain cancer	0.000478	0.000876	CcSEcCtD
Zaleplon—Dermatitis—Carmustine—brain cancer	0.000478	0.000875	CcSEcCtD
Zaleplon—Headache—Carmustine—brain cancer	0.000475	0.00087	CcSEcCtD
Zaleplon—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000467	0.024	CbGpPWpGaD
Zaleplon—Urticaria—Etoposide—brain cancer	0.000466	0.000853	CcSEcCtD
Zaleplon—Abdominal pain—Etoposide—brain cancer	0.000464	0.000849	CcSEcCtD
Zaleplon—Body temperature increased—Etoposide—brain cancer	0.000464	0.000849	CcSEcCtD
Zaleplon—Rash—Temozolomide—brain cancer	0.000462	0.000846	CcSEcCtD
Zaleplon—Dermatitis—Temozolomide—brain cancer	0.000462	0.000846	CcSEcCtD
Zaleplon—Headache—Temozolomide—brain cancer	0.000459	0.000841	CcSEcCtD
Zaleplon—Nausea—Carmustine—brain cancer	0.000451	0.000825	CcSEcCtD
Zaleplon—Nausea—Temozolomide—brain cancer	0.000435	0.000797	CcSEcCtD
Zaleplon—Asthenia—Etoposide—brain cancer	0.000421	0.000771	CcSEcCtD
Zaleplon—Pruritus—Etoposide—brain cancer	0.000415	0.00076	CcSEcCtD
Zaleplon—GABRB2—Orphan transporters—S100A10—brain cancer	0.000413	0.0213	CbGpPWpGaD
Zaleplon—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000391	0.0201	CbGpPWpGaD
Zaleplon—Dizziness—Etoposide—brain cancer	0.000388	0.00071	CcSEcCtD
Zaleplon—GABRA2—Orphan transporters—S100A10—brain cancer	0.000388	0.0199	CbGpPWpGaD
Zaleplon—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000386	0.0198	CbGpPWpGaD
Zaleplon—GABRB3—Orphan transporters—S100A10—brain cancer	0.000385	0.0198	CbGpPWpGaD
Zaleplon—GABRG2—Orphan transporters—S100A10—brain cancer	0.000378	0.0194	CbGpPWpGaD
Zaleplon—Rash—Etoposide—brain cancer	0.00037	0.000677	CcSEcCtD
Zaleplon—Dermatitis—Etoposide—brain cancer	0.000369	0.000677	CcSEcCtD
Zaleplon—Headache—Etoposide—brain cancer	0.000367	0.000673	CcSEcCtD
Zaleplon—Nausea—Etoposide—brain cancer	0.000348	0.000638	CcSEcCtD
Zaleplon—GABRA1—Orphan transporters—S100A10—brain cancer	0.00033	0.017	CbGpPWpGaD
Zaleplon—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000317	0.0163	CbGpPWpGaD
Zaleplon—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000316	0.0163	CbGpPWpGaD
Zaleplon—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000304	0.0156	CbGpPWpGaD
Zaleplon—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000283	0.0145	CbGpPWpGaD
Zaleplon—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000279	0.0143	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—NTRK3—brain cancer	0.000276	0.0142	CbGpPWpGaD
Zaleplon—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.00024	0.0123	CbGpPWpGaD
Zaleplon—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000229	0.0118	CbGpPWpGaD
Zaleplon—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000217	0.0112	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000215	0.0111	CbGpPWpGaD
Zaleplon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000207	0.0106	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000168	0.00866	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000166	0.00854	CbGpPWpGaD
Zaleplon—GABRB2—Ion channel transport—TRPC6—brain cancer	0.000134	0.00688	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000131	0.00676	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00013	0.00667	CbGpPWpGaD
Zaleplon—GABRA2—Ion channel transport—TRPC6—brain cancer	0.000126	0.00645	CbGpPWpGaD
Zaleplon—GABRB3—Ion channel transport—TRPC6—brain cancer	0.000125	0.00641	CbGpPWpGaD
Zaleplon—GABRG2—Ion channel transport—TRPC6—brain cancer	0.000122	0.0063	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000122	0.00626	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.00012	0.00617	CbGpPWpGaD
Zaleplon—AOX1—Disease—DTX2—brain cancer	0.000113	0.00583	CbGpPWpGaD
Zaleplon—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000112	0.00574	CbGpPWpGaD
Zaleplon—GABRA1—Ion channel transport—TRPC6—brain cancer	0.000107	0.0055	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000107	0.00548	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000101	0.00519	CbGpPWpGaD
Zaleplon—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	9.9e-05	0.00509	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—S100A10—brain cancer	9.46e-05	0.00486	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—S100A10—brain cancer	9.4e-05	0.00483	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—S100A10—brain cancer	9.23e-05	0.00475	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	9.15e-05	0.00471	CbGpPWpGaD
Zaleplon—AOX1—Disease—HES5—brain cancer	8.32e-05	0.00428	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—SPP1—brain cancer	8.16e-05	0.0042	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	8.07e-05	0.00415	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—IRS2—brain cancer	7.38e-05	0.0038	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	7.11e-05	0.00366	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—APC—brain cancer	6.52e-05	0.00335	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2C9—brain cancer	6.41e-05	0.0033	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.66e-05	0.00291	CbGpPWpGaD
Zaleplon—AOX1—Disease—IDH1—brain cancer	5.6e-05	0.00288	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.58e-05	0.00287	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—BSG—brain cancer	5.45e-05	0.0028	CbGpPWpGaD
Zaleplon—AOX1—Disease—HEY1—brain cancer	5.31e-05	0.00273	CbGpPWpGaD
Zaleplon—AOX1—Disease—DLL1—brain cancer	5.2e-05	0.00268	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—RELA—brain cancer	5.09e-05	0.00262	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—IDH1—brain cancer	4.69e-05	0.00241	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.66e-05	0.0024	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—CTNNB1—brain cancer	4.43e-05	0.00228	CbGpPWpGaD
Zaleplon—AOX1—Disease—SHH—brain cancer	4.42e-05	0.00228	CbGpPWpGaD
Zaleplon—AOX1—Disease—ENO2—brain cancer	4.42e-05	0.00228	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.37e-05	0.00225	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—TRPC6—brain cancer	4.34e-05	0.00223	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.26e-05	0.00219	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—STAT3—brain cancer	3.86e-05	0.00199	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.73e-05	0.00192	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ENO2—brain cancer	3.71e-05	0.00191	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.57e-05	0.00183	CbGpPWpGaD
Zaleplon—AOX1—Disease—VAV1—brain cancer	3.2e-05	0.00164	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.14e-05	0.00161	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2C9—brain cancer	2.88e-05	0.00148	CbGpPWpGaD
Zaleplon—AOX1—Disease—HES1—brain cancer	2.75e-05	0.00141	CbGpPWpGaD
Zaleplon—AOX1—Disease—PDGFRA—brain cancer	2.62e-05	0.00135	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BSG—brain cancer	2.45e-05	0.00126	CbGpPWpGaD
Zaleplon—AOX1—Disease—IRS2—brain cancer	2.3e-05	0.00118	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—IDH1—brain cancer	2.11e-05	0.00108	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2C9—brain cancer	2.08e-05	0.00107	CbGpPWpGaD
Zaleplon—AOX1—Disease—APC—brain cancer	2.03e-05	0.00104	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BSG—brain cancer	1.77e-05	0.00091	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CG—brain cancer	1.7e-05	0.000874	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ENO2—brain cancer	1.66e-05	0.000856	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB2—brain cancer	1.58e-05	0.00081	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—IDH1—brain cancer	1.52e-05	0.000782	CbGpPWpGaD
Zaleplon—AOX1—Disease—CTNNB1—brain cancer	1.38e-05	0.000709	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ENO2—brain cancer	1.2e-05	0.000618	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—brain cancer	1.2e-05	0.000618	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—brain cancer	1.12e-05	0.000574	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—brain cancer	1.09e-05	0.000562	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2C9—brain cancer	9.67e-06	0.000497	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BSG—brain cancer	8.23e-06	0.000423	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CG—brain cancer	7.63e-06	0.000393	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—IDH1—brain cancer	7.07e-06	0.000364	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ENO2—brain cancer	5.59e-06	0.000288	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CG—brain cancer	5.52e-06	0.000284	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CG—brain cancer	2.57e-06	0.000132	CbGpPWpGaD
